SYS-CON MEDIA Authors: Jayaram Krishnaswamy, Gilad Parann-Nissany, Unitiv Blog, Bob Gourley, Kevin Benedict

News Feed Item

North American Life Science Sector Plans 264 New Facilities With Potential $22 Billion Capital Investment, an Industrial Info News Alert

SUGAR LAND, TX -- (Marketwire) -- 01/29/13 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Despite a prevailing economic pessimism, life science planners are proving to be a rather optimistic bunch. In North America alone, there are currently 264 projects representing a total investment value (TIV) of $21.6 billion in active development. Drawn from reported projects with a future kick-off date from Industrial Info's Pharmaceutical Tracker - Online Database, all are in various stages of planning, ranging from early market analysis to detailed engineering.

Other companies featured: Baxter International Corporation (NYSE:BAX), Johnson & Johnson (NYSE:JNJ)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showAbstract.jsp?newsitemID=233020&refer=mw, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the www.industrialinfo.com "Contact Us" page.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Joe Govreau
713-783-5147

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.